IP Library Patent Application 19014583
Patent Application
App. No. 19/014,583

METHOD OF PRODUCING PHYSIOLOGICAL AND THERAPEUTIC LEVELS OF NITRIC OXIDE THROUGH AN ORAL DELIVERY SYSTEM

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
19/014,583
Abstract

A composition and method of providing nitric oxide and nitrite therapy to patients whereby a therapeutic amount is bioavailable within approximately 30 minutes of administration. In embodiments of the invention, nitric oxide is produced in the oral cavity.

Claims (20)

1 . A delivery system comprising:

beet root, Vitamin C, and an agent that reduces nitrite to nitric oxide; and

a dispersable medium adapted to be consumed in the oral cavity;

wherein the nitric oxide-producing component is adapted to generate nitric oxide in vivo upon consumption of the dispersable medium.

2 . The delivery system of claim 1 , wherein the dispersable medium is dissolvable in the oral cavity.

3 . The delivery system of claim 1 , wherein the dispersable medium is dissolvable in about five minutes or less.

4 . The delivery system of claim 1 , wherein the delivery system is adapted to generate nitric oxide in the oral cavity.

5 . The delivery system of claim 1 , where the nitric oxide-producing component is adapted to generate nitric oxide in-vivo in response to dissolution of the delivery system in the gastro intestinal tract.

6 . The delivery system of claim 1 , wherein the delivery system is formed of a lozenge, liquid, powder, solid, semi-solid, cream, gel, emulsion, suspension, heterogenic liquid, film, or topical.

7 . The delivery system of claim 1 , wherein the dispersable medium comprises one or more of a sugar, dispersing agent, flavor, sweetener, color, alcohol, maltodextren, or filler.

8 . The delivery system of claim 1 , wherein the nitric oxide-producing component is comprised of a nitrite, nitrate, or reductase or a combination of nitrite, nitrate and reductase.

9 . The delivery system of claim 1 further comprising a barrier for preventing contact of two or more species of the nitric oxide-producing component.

10 . The delivery system of claim 9 , wherein the two or more species are nitrite and nitrite reductase.

11 . The delivery system of claim 9 , wherein the barrier comprises sugar, dispersing agent, flavors, sweetener, color, alcohol, maltodextren, or filler.

12 . The delivery system of claim 1 further comprising a disintegrating agent, a compactible excipient, or both.

13 . The delivery system of claim 12 , wherein the disintegrating agent absorbs fluid upon contact with fluid.

14 . The delivery system of claim 12 , wherein the compactable excipient is adapted to maintain the delivery system in a compressed form.

15 . The delivery system of claim 12 , wherein the compactable excipient is chemically inert, does not absorb fluid, is non-hydroscopic, protects water-sensitive nitric oxide-producing components, does not react with nitric oxide-producing components and/or has a narrow particle size distribution.

16 . The delivery system of claim 12 wherein the disintegrating agent causes the compactable excipient to break apart upon expansion.

17 . The delivery system of claim 1 , wherein the agent that reduces nitrite to nitric oxide is stevia , hemoglobin, myoglobin, or xanthine oxidoreductase.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 9, 2025
From: BRYAN, NATHAN S.
To: BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 069799/0957 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 9, 2025
From: ROCCA, JOSE G.
To: NEOGENIS LABORATORIES, INC.
Reel/Frame 069800/0102 →
CHANGE OF NAME Recorded Jan 9, 2025
From: NEOGENIS LABORATORIES, INC.
To: HUMAN POWER OF N COMPANY
Reel/Frame 069858/0065 →